Condition
Advanced/Metastatic Colorectal Cancer
Total Trials
4
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
4Total
P 1 (2)
P 2 (2)
Trial Status
Unknown3
Not Yet Recruiting1
Clinical Trials (4)
Showing 4 of 4 trials
NCT06322563Phase 2Not Yet RecruitingPrimary
Combination of LTC004 and Regorafenib to Treat Patients With Advanced/Metastatic CRC
NCT05480280Phase 2UnknownPrimary
mFOLFOX6 Combined With Dalpiciclib in Patients With Metastatic Colorectal Cancer
NCT03260179Phase 1Unknown
Study to Evaluate the Safety, Preliminary Efficacy and Pharmacokinetics of 3810
NCT02870036Phase 1Unknown
Study to Evaluate the Safety, Tolerability, Preliminary Efficacy and Pharmacokinetics of Simmitecan Monotherapy and Combination in Patients With Advanced Solid Tumors
Showing all 4 trials